ORIGINAL RESEARCH
Accepted on 23 Jun 2025
Corresponding author：Jingfu Wang；Xiaorong Sun
doi 10.3389/fmed.2025.1596272
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Development and Validation of New Molecular Probes of Nuclear Medicine and New Targets of Nuclear Drugs in Cancers
Development and Validation of New Molecular Probes of Nuclear Medicine and New Targets of Nuclear Drugs in Cancers
970
Total downloads
6,150
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 04 Jun 2025
SPAG6 Promotes Multiple Myeloma Through Activation of the MAPK/ERK Signaling Pathway
doi 10.3389/fphar.2025.1572621
- 521 views
ORIGINAL RESEARCH
Published on 15 May 2025
Preclinical studies of a PARP-targeted theranostic radiopharmaceutical for pancreatic cancer
doi 10.3389/fphar.2025.1576587
- 796 views
REVIEW
Published on 14 May 2025
Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy
doi 10.3389/fphar.2025.1593380
- 1,178 views
REVIEW
Published on 08 May 2025
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives
doi 10.3389/fphar.2025.1559236
- 1,187 views
ORIGINAL RESEARCH
Published on 10 Apr 2025
Predictive significance of 18F-FDG PET/CT metabolic parameters for the expression level of HER2 in gastric cancer
doi 10.3389/fonc.2025.1580166
- 722 views
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Medicine
- 3.0 impact factor
- 6.0 citescore
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: